Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. UNH
stocks logo

UNH

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
111.99B
+13.29%
6.194
-8.91%
114.09B
+13.16%
6.661
-6.84%
115.17B
+14.25%
6.144
-9.78%
Estimates Revision
The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.32% over the past three months. During the same period, the stock price has changed by -28.19%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.32%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-12%
In Past 3 Month
Stock Price
Go Down
down Image
-28.19%
In Past 3 Month
25 Analyst Rating
up Image0
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 559.13 USD with a low forecast of 490.00 USD and a high forecast of 700.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
22 Buy
3 Hold
0 Sell
Strong Buy
up Image0
Current: 378.750
sliders
Low
490.00
Averages
559.13
High
700.00
up Image0
Current: 378.750
sliders
Low
490.00
Averages
559.13
High
700.00
Baird
Michael Ha
Buy
Maintains
$640 → $510
2025-04-29
Reason
Baird
Michael Ha
Price Target
$640 → $510
2025-04-29
Maintains
Buy
Reason
Baird analyst Michael Ha lowered the firm's price target on UnitedHealth to $510 from $640 and keeps an Outperform rating on the shares. The firm updated its model and said it remains their number one pick.
JP Morgan
Lisa Gill
Buy
Maintains
$652 → $525
2025-04-24
Reason
JP Morgan
Lisa Gill
Price Target
$652 → $525
2025-04-24
Maintains
Buy
Reason
Barclays
Andrew Mok
Buy
Maintains
$560 → $513
2025-04-24
Reason
Barclays
Andrew Mok
Price Target
$560 → $513
2025-04-24
Maintains
Buy
Reason
Barclays lowered the firm's price target on UnitedHealth to $560 from $642 and keeps an Overweight rating on the shares following the Q1 report.
RBC Capital
Ben Hendrix
Buy
Maintains
$655 → $525
2025-04-23
Reason
RBC Capital
Ben Hendrix
Price Target
$655 → $525
2025-04-23
Maintains
Buy
Reason
RBC Capital lowered the firm's price target on UnitedHealth to $525 from $655 but keeps an Outperform rating on the shares. The firm is updating its model following the company's Q1 earnings miss earlier this month, though the management's early recognition of lower engagement of new Optum Health members leading to lower-than-expected reimbursement levels as well as higher-than-expected Medicare Advantage utilization should inform accurate 2026 pricing, giving RBC confidence that these headwinds are addressable in the intermediate term, the analyst tells investors in a research note.
Morgan Stanley
Ricky Goldwasser
Buy
Maintains
$664 → $563
2025-04-22
Reason
Morgan Stanley
Ricky Goldwasser
Price Target
$664 → $563
2025-04-22
Maintains
Buy
Reason
Morgan Stanley analyst Erin Wright raised the firm's price target on UnitedHealth to $664 from $610 and keeps an Overweight rating on the shares. While policy will be "front and center" with varying degrees of exposure, or lack there of, across the Healthcare Services and Technology space, the focus will also be on indications of underlying utilization trends across MCOs, distributors, providers, labs, animal and dental into Q1, the analyst tells investors in a preview for the group.
HSBC
Sidharth Sahoo
Strong Buy
to
Hold
Downgrades
n/a
2025-04-22
Reason
HSBC
Sidharth Sahoo
Price Target
n/a
2025-04-22
Downgrades
Strong Buy
to
Hold
Reason
HSBC downgraded UnitedHealth to Hold from Buy with a $490 price target.
See All Ratings

Valuation Metrics

The current forward P/E ratio for UnitedHealth Group Inc (UNH.N) is 13.98, compared to its 5-year average forward P/E of 19.97. For a more detailed relative valuation and DCF analysis to assess UnitedHealth Group Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PE
19.97
Current PE
13.98
Overvalued PE
21.98
Undervalued PE
17.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average EV/EBITDA
14.15
Current EV/EBITDA
10.41
Overvalued EV/EBITDA
15.52
Undervalued EV/EBITDA
12.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PS
1.24
Current PS
0.75
Overvalued PS
1.39
Undervalued PS
1.10

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

UNH News & Events

Events Timeline

(ET)
2025-05-12
10:59:57
White House publishes Trump executive order aimed at lowering drug prices
select
link
2025-05-12
10:28:47
Trump says will 'cut out middlemen' to reduce drug prices
select
2025-05-12
06:21:41
Proposal to cut Medicaid spending aims for GOP middle ground, WSJ says
select
link
Sign Up For More Events
Sign Up For More Events

News

Preview
8.0
04:53 AMReuters
Trump's drug pricing order delivers blow to pharmacy benefit managers

  • Trump's Executive Order on Drug Pricing: President Trump announced an executive order aimed at eliminating middlemen in drug pricing, allowing direct sales of drugs to consumers at prices comparable to those in Europe, which caused a drop in shares for pharmacy benefit managers like CVS and Cigna.

  • Impact on Pharmaceutical Industry: The order is expected to maintain pressure on pharmacy benefit managers due to their role in high drug prices, while analysts suggest that the reliance on employer-sponsored health plans may complicate its implementation.

Preview
7.0
05-12PRnewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

  • Class Action Lawsuit Filed: A class action lawsuit has been initiated against UnitedHealth Group for alleged securities fraud and unlawful business practices, with investors encouraged to contact Pomerantz LLP for participation by July 7, 2025.

  • Stock Price Impact: Following a press release on April 17, 2025, where UnitedHealth revised its earnings outlook significantly downward, the company's stock price dropped by 27% over two trading sessions.

Preview
7.0
05-12SeekingAlpha
Amedisys edges lower on report DOJ initially rejects remedy in UnitedHealth

  • DOJ's Rejection of Amedisys Sale: The Department of Justice has initially rejected the proposed divestiture buyers for Amedisys' planned sale to UnitedHealth, citing concerns about maintaining competition in the home-health and hospice market.

  • Ongoing Negotiations: Discussions between Amedisys, UnitedHealth, and DOJ staff are ongoing, with a supplemental mediation conference scheduled for August 28 to facilitate negotiations following an upcoming meeting on August 18.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is UnitedHealth Group Inc (UNH) stock price today?

The current price of UNH is 378.75 USD — it has decreased -0.5 % in the last trading day.

arrow icon

What is UnitedHealth Group Inc (UNH)'s business?

UnitedHealth Group Incorporated is a healthcare company. The Company has two businesses, Optum and UnitedHealthcare. Optum serves the health care marketplace, including patients and consumers, payers, care providers, employers, governments and life sciences companies. UnitedHealthcare offers a full range of health benefits designed to simplify the health care experience and make it more affordable for consumers to access care. UnitedHealthcare Employer & Individual serves consumers and employers, ranging from sole proprietorships to large, multi-site and national employers and public sector employers. UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare eligible consumers. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State.

arrow icon

What is the price predicton of UNH Stock?

Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 559.13 USD with a low forecast of 490.00 USD and a high forecast of 700.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is UnitedHealth Group Inc (UNH)'s revenue for the last quarter?

UnitedHealth Group Inc revenue for the last quarter amounts to 109.58B USD, increased 9.80 % YoY.

arrow icon

What is UnitedHealth Group Inc (UNH)'s earnings per share (EPS) for the last quarter?

UnitedHealth Group Inc. EPS for the last quarter amounts to 6.85 USD, decreased -547.71 % YoY.

arrow icon

What changes have occurred in the market's expectations for UnitedHealth Group Inc (UNH)'s fundamentals?

The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.32% over the past three months. During the same period, the stock price has changed by -28.19%.
arrow icon

How many employees does UnitedHealth Group Inc (UNH). have?

UnitedHealth Group Inc (UNH) has 440000 emplpoyees as of May 13 2025.

arrow icon

What is UnitedHealth Group Inc (UNH) market cap?

Today UNH has the market capitalization of 343.58B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free